Xylem (XYL) Revenue (2010 - 2026)

Xylem has reported Revenue for 17 years, with the latest figure at $2.3 billion in Q2 2026.

• On a quarterly basis, Revenue rose 1.52% year-over-year to $2.3 billion in Q2 2026; TTM through Jun 2026 was $9.1 billion, a 4.54% increase from a year earlier, with the FY2025 full-year figure at $9.0 billion, up 5.52% from the prior year.
• Revenue was $2.3 billion for Q2 2026 at Xylem, up from $2.1 billion in the prior quarter.
• The five-year high for Revenue was $2.4 billion in Q4 2025, with the low at $1.3 billion in Q1 2022.
• Average Revenue over 5 years is $1.9 billion, with a median of $2.1 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Revenue increased 0.96% in 2022, then jumped 50.43% in 2023.
• Over 5 years, Revenue stood at $1.5 billion in 2022, then surged by 40.64% to $2.1 billion in 2023, then climbed by 6.52% to $2.3 billion in 2024, then grew by 6.25% to $2.4 billion in 2025, then declined by 2.54% to $2.3 billion in 2026.
• The last three Revenue figures came in at $2.3 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.4 billion (Q4 2025), per Business Quant data.